Disclosed in a recent SEC filing on January 15, Schmidt, Director at Astrana Health (NASDAQ:ASTH), made a noteworthy transaction involving the exercise of company stock options. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Thursday showed that Schmidt,…
Continue reading...